Preferred Label : mifepristone;
MeSH definition : A progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone
induces bleeding during the luteal phase and in early pregnancy by releasing endogenous
prostaglandins from the endometrium or decidua. As a glucocorticoid receptor antagonist,
the drug has been used to treat hypercortisolism in patients with nonpituitary CUSHING
SYNDROME.;
CISMeF synonym : danco brand of mifepristone; mifepristone danco brand; exelgyn brand of mifepristone; mifepristone exelgyn brand; contragest brand of mifepristone; mifepristone contragest brand;
DeCS synonym : Mif gyne;
MeSH hyponym : ru 486; mifégyne; mifegyne; R-38486; mifeprex; R 38486; RU-486; RU486; R38486; RU-38486; RU 38486; RU38486;
Related MeSH term : ZK-98296; ZK 98296; ZK98296;
MeSH CAS label : Estra-4,9-dien-3-one, 11-(4-(dimethylamino)phenyl)-17-hydroxy-17-(1-propynyl)-, (11beta,17beta)-;
MeSH Related Number : 84371-65-3 (Mifepristone);
Registry Number MeSH : 84371-65-3;
Wikipedia link : https://en.wikipedia.org/wiki/Mifepristone;
Is substance : O;
UNII : 320T6RNW1F;
InChIKey : VKHAHZOOUSRJNA-GCNJZUOMSA-N;
Origin ID : D015735;
UMLS CUI : C0026088;
ATC code(s)
- Allowable qualifiers
- CISMeF manual mappings
- Currated CISMeF NLP mapping
- Fils d'après SNOMED CT
- Pharmacological action(s)
- Record concept(s)
- Related MeSH Supplementary Concept(s)
- RU49953 [MeSH Supplementary Concept]
- corlux [MeSH Supplementary Concept]
- See also (suggested by CISMeF)
- Semantic type(s)
- UMLS correspondences (same concept)
- Validated automatic mappings to BTNT
A progestational and glucocorticoid hormone antagonist. Its inhibition of progesterone
induces bleeding during the luteal phase and in early pregnancy by releasing endogenous
prostaglandins from the endometrium or decidua. As a glucocorticoid receptor antagonist,
the drug has been used to treat hypercortisolism in patients with nonpituitary CUSHING
SYNDROME.
https://ansm.sante.fr/tableau-acces-derogatoire/gymiso-200-microgrammes-comprime-1
2024
false
false
false
France
French
misoprostol
mifepristone
drug information
continuity of patient care
Early Pregnancy Loss
---
https://www.has-sante.fr/jcms/p_3223429/fr/interruption-volontaire-de-grossesse-par-methode-medicamenteuse-mise-a-jour
2021
false
France
French
abortion, Drug-Induced
insurance, health, reimbursement
mifepristone
misoprostol
administration, oral
continuity of patient care
pregnancy trimester, first
Gestation less than 9 weeks (finding)
office visits
abortion, induced
abortifacient agents, steroidal
misoprostol
drug therapy, combination
mifepristone
practice guideline
---
https://www.has-sante.fr/portail/jcms/c_2966258/fr/miffee
https://www.has-sante.fr/portail/jcms/c_2966258/fr/miffee-mifepristone-modulateur-des-recepteurs-de-la-progesterone
2019
false
France
French
abortion, Drug-Induced
treatment outcome
hormone antagonists
hormone antagonists
receptors, progesterone
guidelines for drug use
evaluation of the transparency committee
mifepristone
mifepristone
mifepristone
administration, oral
abortifacient agents, steroidal
abortifacient agents, steroidal
abortion, induced
drug therapy, combination
---
https://www.has-sante.fr/jcms/c_2966258/fr/miffee
2019
false
false
false
France
mifepristone
abortifacient agents, steroidal
hormone antagonists
insurance, health, reimbursement
abortion, Drug-Induced
drug therapy, combination
administration, oral
mifepristone
evaluation of the transparency committee
abortion, induced
---
https://www.has-sante.fr/portail/jcms/c_2888468/fr/mifegyne
2018
false
false
false
France
evaluation of the transparency committee
mifegyne
mifepristone
---
https://dumas.ccsd.cnrs.fr/dumas-02114334
2018
France
dissertations, academic
elective abortion
tablets
mifepristone
referral and consultation
consultants
video recording
drug, nos
abortion, induced
upstream
abortion, Drug-Induced
hand strength
consultants
---
http://www.cochrane.org/fr/CD010770/medicaments-pour-traiter-les-fibromes
2017
false
false
false
France
United Kingdom
French
french abstract
premenopause
fibroid uterus
Evidence-Based medicine
treatment outcome
progesterone receptor modulators
review of literature
mifepristone
ulipristal acetate
comparative effectiveness research
asoprisnil
leuprolide acetate
receptors, progesterone
leiomyoma
leuprolide
norpregnadienes
estrenes
oximes
---
http://www.has-sante.fr/portail/jcms/c_2747019/fr/miffee
http://www.has-sante.fr/portail/jcms/c_2747019/fr/miffee-mifepristone-modulateur-des-recepteurs-de-la-progesterone
2017
false
France
French
abortion, Drug-Induced
treatment outcome
guidelines for drug use
hormone antagonists
hormone antagonists
receptors, progesterone
evaluation of the transparency committee
mifepristone
mifepristone
mifepristone
administration, oral
abortifacient agents, steroidal
abortifacient agents, steroidal
abortion, induced
drug therapy, combination
---
Health Canada updates prescribing and dispensing information for Mifegymiso
http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2017/65034a-fra.php
http://canadiensensante.gc.ca/recall-alert-rappel-avis/hc-sc/2017/65030a-fra.php
2017
false
false
false
Canada
French
English
abortion, therapeutic
guidelines for drug use
patients guideline
administration, oral
administration, buccal
drug therapy, combination
mifepristone
mifepristone
drug labeling
abortifacient agents, steroidal
abortifacient agents, steroidal
misoprostol
misoprostol
abortifacient agents, nonsteroidal
abortifacient agents, nonsteroidal
risk management
informed consent
---
Progesterone receptor modulators for endometriosis
http://www.cochrane.org/fr/CD009881/les-modulateurs-des-recepteurs-de-la-progesterone-contre-lendometriose
2017
false
false
false
France
United Kingdom
French
English
french abstract
endometriosis
treatment outcome
Evidence-Based medicine
mifepristone
mifepristone
dysmenorrhea
dyspareunia
progesterone receptor modulators
receptors, progesterone
review of literature
ulipristal
ulipristal acetate
randomized controlled trials as topic
hot flashes
amenorrhea
norpregnadienes
---
MIFEGYMISO - Summary Basis of Decision
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00239
2016
false
false
false
false
Canada
French
English
summary of product characteristics
canada
drug approval
drug antagonism
administration, oral
administration, buccal
misoprostol
misoprostol
mifepristone
mifepristone
abortifacient agents, nonsteroidal
abortifacient agents, nonsteroidal
abortifacient agents, steroidal
abortifacient agents, steroidal
abortion, Drug-Induced
risk assessment
drug evaluation
abortion, induced
---
https://medicalforum.ch/fr/detail/doi/fms.2015.02375/
2015
false
false
false
Switzerland
French
journal article
abortion, induced
mifepristone
misoprostol
abortifacient agents, nonsteroidal
abortifacient agents, steroidal
---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=68295219
2014
false
false
false
France
French
summary of product characteristics
package leaflet
tablets
compression, nos
pill, nos
mifepristone
---
http://www.lecrat.eu/?s=Mif%C3%A9pristone+%3D+RU+486
2013
France
French
mifepristone
mifepristone
abortifacient agents, steroidal
pregnancy
drug information
---
http://www.has-sante.fr/portail/jcms/c_1670209/fr/miffee
http://www.has-sante.fr/portail/jcms/c_1670208/fr/miffee-16102013-avis-ct12916
2013
false
France
French
guidelines for drug use
evaluation of the transparency committee
mifepristone
mifepristone
mifepristone
administration, oral
abortifacient agents, steroidal
abortifacient agents, steroidal
abortion, induced
drug therapy, combination
---
http://www.cochrane.org/fr/CD007687
2012
United Kingdom
France
French
meta-analysis
mifepristone
leiomyoma
treatment outcome
receptors, progesterone
french abstract
---
http://www.cochrane.org/fr/CD002855
2011
false
true
false
France
United Kingdom
abortion, induced
prostaglandins
mifepristone
pregnancy
treatment outcome
methotrexate
review of literature
french abstract
pregnancy trimester, first
---
http://www.has-sante.fr/portail/jcms/c_961137/interruption-volontaire-de-grossesse-par-methode-medicamenteuse
http://www.has-sante.fr/portail/jcms/c_1049424/ivg-methode-medicamenteuse-argumentaire-mel
2011
true
France
French
abortion, induced
abortifacient agents, steroidal
misoprostol
prostaglandins
drug therapy, combination
misoprostol
mifepristone
mifepristone
abortion, induced
practice guideline
---
http://www.cochrane.org/fr/CD005216
2011
false
true
false
France
United Kingdom
abortion, induced
pregnancy
misoprostol
mifepristone
review of literature
french abstract
pregnancy trimester, second
---
http://www.cochrane.org/fr/CD007207
2010
United Kingdom
France
French
french abstract
meta-analysis
pregnancy trimester, first
abortion, induced
preoperative care
mifepristone
misoprostol
abortifacient agents, nonsteroidal
cervical ripening
---
http://www.cochrane.org/fr/CD002865
2009
false
true
false
United Kingdom
France
labor, induced
treatment outcome
review of literature
french abstract
labor onset
mifepristone
---
https://www.sggg.ch/fileadmin/user_upload/Dokumente/3_Fachinformationen/1_Expertenbriefe/Fr/15_Mifepristone_2008.pdf
2008
Switzerland
guideline
pregnancy trimester, first
expert testimony
drug, nos
mifepristone
Acanthocytosis
pharmaceutical preparations
first trimester pregnancy
disruption, nos
expert opinion
---
https://dumas.ccsd.cnrs.fr/dumas-03232053
1992
France
dissertations, academic
heart failure, Left-Sided
abortion on demand
Pulmonary atresia
Applications
Applications
data collection
attention
Applications
mifepristone
Left ventricular failure
heart failure
abortion, legal
---
